An Epic investigation, a Teladoc surprise, and figuring out how to pay for AI.

Now, the debate has turned to the impact of the proposed rule, which is more aggressive than some anticipated. A Treasury ...

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.

For years, scientists have struggled to elucidate key biological differences between early onset colorectal cancer, typically ...

Abdul El-Sayed has made headlines for his progressive politics and stance on Israel. But some supporters consider his public ...

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted ...

After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary ...

A House lawmaker asked the Government Accountability Office to review whether the TrumpRx platform has saved Americans any ...

Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight ...

This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine.

Kennedy and his MAHA movement have embraced peptides, though there's little evidence for many of the wellness compounds.

The Trump administration removed several security, privacy and transparency requirements for vendors of EHR software.